Literature DB >> 1597200

Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature.

J Collazos1, J de Miguel, R Ayarza.   

Abstract

Moraxella (formerly Branhamella) catarrhalis is a gram-negative coccus now recognized as one of the common pathogens in respiratory infections. Documented cases of bacteremic pneumonia due to this organism, however, have been a rarity. Two cases of Moraxella catarrhalis bacteremic pneumonia in immunosuppressed adult patients are reported. The clinical characteristics of these patients together with those of the seven adult and the six pediatric patients reported to date in the literature, are analyzed. All patients had an underlying condition and most were male. The mean age was 64.9 years. No adult patient had skin lesion, although purpuric rash was frequent in children. The overall morality rate was only 13.3%, in spite of the underlying diseases. In three patients the pneumonia was nosocomial. The seasonal recovery of Moraxella catarrhalis in respiratory infections is significantly increased during the late fall through early spring period. Because most strains are beta-lactamase positive, empiric use of penicillin, ampicillin or amoxicillin for this organism can no longer be recommended.

Entities:  

Mesh:

Year:  1992        PMID: 1597200     DOI: 10.1007/bf02098086

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  From Micrococcus to Moraxella. The reemergence of Branhamella catarrhalis.

Authors:  S L Berk
Journal:  Arch Intern Med       Date:  1990-11

2.  A comparison of serum bactericidal activity and phenotypic characteristics of bacteremic, pneumonia-causing strains, and colonizing strains of Branhamella catarrhalis.

Authors:  K L Jordan; S H Berk; S L Berk
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

Review 3.  Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis.

Authors:  R J Wallace; D R Nash; V A Steingrube
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

Review 4.  The increasing importance of Branhamella catarrhalis in respiratory infections.

Authors:  G F Van Hare; P A Shurin
Journal:  Pediatr Infect Dis J       Date:  1987-01       Impact factor: 2.129

5.  Fatal sepsis due to Branhamella catarrhalis and Hemophilus influenzae in a child with selective IgG deficiency.

Authors:  J Bryant
Journal:  Arch Pathol Lab Med       Date:  1983-08       Impact factor: 5.534

6.  Branhamella catarrhalis pneumonia with bacteremia.

Authors:  P W Choo; N M Gantz
Journal:  South Med J       Date:  1989-10       Impact factor: 0.954

7.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Branhamella catarrhalis septicemia in patients with leukemia.

Authors:  H Saito; E J Anaissie; N Khardori; G P Bodey
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

9.  Development of bactericidal antibody during Branhamella catarrhalis infection.

Authors:  A J Chapman; D M Musher; S Jonsson; J E Clarridge; R J Wallace
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Branhamella catarrhalis as a cause of bacteremic pneumonia.

Authors:  M Malkamäki; E Honkanen; M Leinonen; P H Mäkelä
Journal:  Scand J Infect Dis       Date:  1983
View more
  8 in total

Review 1.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 2.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

Review 3.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

4.  Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations.

Authors:  Kirsten M Kloepfer; Wai Ming Lee; Tressa E Pappas; Theresa J Kang; Rose F Vrtis; Michael D Evans; Ronald E Gangnon; Yury A Bochkov; Daniel J Jackson; Robert F Lemanske; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2014-04-01       Impact factor: 10.793

5.  Pneumonia caused by Moraxella catarrhalis in haematopoietic stem cell transplant patients. Report of two cases and review of the literature.

Authors:  Ka Al-Anazi; Fa Al-Fraih; Na Chaudhri; Fi Al-Mohareb
Journal:  Libyan J Med       Date:  2007-09-01       Impact factor: 1.657

Review 6.  Secondary Bacterial Infections Associated with Influenza Pandemics.

Authors:  Denise E Morris; David W Cleary; Stuart C Clarke
Journal:  Front Microbiol       Date:  2017-06-23       Impact factor: 5.640

7.  A Case of Polymicrobial Bacteremia in a Patient Undergoing Chemotherapy.

Authors:  Kyoko Arahata; Ryo Yamaguchi; Takeshi Terashima
Journal:  Case Rep Infect Dis       Date:  2018-01-15

8.  Moraxella catarrhalis bacteremic pneumonia.

Authors:  Hiroki Anezaki; Norohiko Terada; Takahisa Kawamura; Hanako Kurai
Journal:  IDCases       Date:  2020-02-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.